Medicare Enrolled

Dr. Emily Pineda, M.D.

Rheumatology · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
5414 FREDERICKSBURG RD STE 150, San Antonio, TX 78229
2106159800
In practice since 2006 (20 years)
NPI: 1376512368 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pineda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pineda? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pineda

Dr. Emily Pineda is a rheumatology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pineda performed 35,540 Medicare services across 1,523 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pineda received a total of $18,649 from 42 pharmaceutical and/or device companies across 962 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pineda is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 27% volume in TX $18,649 industry payments

Medicare Practice Summary

Medicare Utilization ↗
35,540
Medicare services
Top 27% in TX for rheumatology
1,523
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,777 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Abatacept infusion (Orencia) 10,075 $33 $88
Romosozumab injection (Evenity) for osteoporosis 8,400 $8 $18
Golimumab infusion (Simponi Aria) 8,150 $10 $29
Denosumab injection (Prolia/Xgeva) 4,920 $18 $45
Office visit, established patient (30-39 min) 1,605 $84 $249
Steroid injection (triamcinolone) 943 $1 $2
Administration of chemotherapy into vein, 1 hour or less 331 $86 $254
Aspiration and/or injection of fluid large joint using ultrasound guidance 223 $73 $222
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 184 $49 $141
Administration of chemotherapy into vein, each additional hour 134 $14 $55
New patient office visit (45-59 min) 94 $113 $324
Office visit, established patient (20-29 min) 84 $62 $176
Aspiration and/or injection of fluid from small joint using ultrasound guidance 82 $59 $160
Injection of additional new drug or substance into vein 78 $6 $30
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose 52 $102 $256
Injection, methylprednisolone sodium succinate, up to 125 mg 45 $3 $12
Ultrasonic guidance for needle placement 39 $44 $114
Injection, methylprednisolone acetate, 40 mg 33 $5 $15
Injection, methylprednisolone acetate, 20 mg 32 $4 $9
Injection into tendon or ligament 22 $43 $113
Aspiration and/or injection of fluid from medium joint using ultrasound guidance 14 $55 $110
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
51.3% high complexity
43.6% medium
5.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$18,649
Total received (2018-2024)
Avg $2,664/year across 7 years
Top 18% in TX for rheumatology
42
Companies
962
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,649 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,781
2023
$2,294
2022
$2,952
2021
$2,700
2020
$2,727
2019
$2,643
2018
$2,552

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,280
Janssen Biotech, Inc.
$2,055
Novartis Pharmaceuticals Corporation
$1,792
Horizon Therapeutics plc
$1,692
UCB, Inc.
$1,242
Mallinckrodt Hospital Products Inc.
$1,045
E.R. Squibb & Sons, L.L.C.
$1,031
ABBVIE INC.
$980
GENZYME CORPORATION
$837
Lilly USA, LLC
$800
Genentech USA, Inc.
$535
GlaxoSmithKline, LLC.
$483
AstraZeneca Pharmaceuticals LP
$457
Antares Pharma, Inc.
$399
AbbVie Inc.
$385
PFIZER INC.
$368
Radius Health, Inc.
$330
AbbVie, Inc.
$308
Mallinckrodt LLC
$258
Exeltis, USA Inc.
$170
Horizon Pharma plc
$150
Johnson & Johnson Health Care Systems Inc.
$150
Janssen Scientific Affairs, LLC
$124
Mallinckrodt Enterprises LLC
$121
Octapharma USA, Inc.
$85
Hikma Pharmaceuticals USA
$73
Sobi, Inc
$55
Aurinia Pharma U.S., Inc.
$54
Ferring Pharmaceuticals Inc.
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Ultragenyx Pharmaceutical Inc.
$43
Cumberland Pharmaceuticals, Inc.
$40
IBSA Pharma Inc.
$35
TerSera Therapeutics LLC
$30
MEDAC PHARMA, INC.
$26
Flexion Therapeutics, Inc.
$25
Zimmer Biomet Holdings, Inc.
$17
Celgene Corporation
$16
Alexion Pharmaceuticals, Inc.
$16
MEDEXUS PHARMA, INC.
$14
SOBI, INC
$13
Avion Pharmaceuticals
$12
Top 3 companies account for 32.9% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · Balcoltra · Bimzelx · COSENTYX · Cimzia · Crysvita · Cryvista · EUFLEXXA · EVENITY · Enbrel · Gel-One Cross-linked Hyaluronate · HUMIRA · Humira · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Licart · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ORENCIA · OTREXUP · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · Quzyttir · RAYOS · REDITREX · REMICADE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SOLIRIS · STELARA · TALTZ · TAVNEOS · TREMFYA · Tirosint · Tymlos · XELJANZ · XYOSTED · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $52 per 100 Medicare services performed
Looking for a rheumatology specialist in San Antonio?
Compare rheumatologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
50
Per 100K population
2.5
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pineda is a mixed practice specialist, with above-average Medicare volume (top 27% in TX), with low-engagement industry engagement in the top 18% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Pineda experienced with abatacept infusion (orencia)?
Based on Medicare claims data, Dr. Pineda performed 10,075 abatacept infusion (orencia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pineda receive payments from pharmaceutical companies?
Yes. Dr. Pineda received a total of $18,649 from 42 companies across 962 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pineda's costs compare to other rheumatologists in San Antonio?
Dr. Pineda's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pineda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →